《大行報告》高盛上調恆地(00012.HK)目標價至33.4元 評級「中性」
高盛發表研究報告指恆地(00012.HK)去年業績符預期,每股基本純利1.99元,按年跌29%,符合該行預期,惟低於市場預期16%。末期息每股派1.3元,按年持平,亦符該行預期;全年度總派息維持1.8元。負債比率由對上一年的28%降至24%,倘計及母企貸款則由對上一年的43%降至41%。
考慮去年下半年盈利及績後管理層解說後,該行降恆地今年每股盈測5%,惟上調明年每股盈測33%,並料今明兩年總派息維持各1.8元,2023至2025年間每年總派息料持平。目標價由32.7元升至33.4元,評級「中性」。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.